United Therapeutics (UTHR) CFO sells 10,000 shares after option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp CFO James Edgemond exercised stock options for 10,000 shares of Common Stock at an exercise price of $135.42 per share and sold 10,000 shares in open-market transactions. The sales occurred on April 16, 2026 in multiple trades at prices reported between $573.9146 and $581.6400 per share.
The filing states that this option exercise and subsequent share sales were made under a pre-arranged Rule 10b5-1 trading plan entered into on October 31, 2025. After these transactions, Edgemond directly holds 18,876 shares of Common Stock and 82,500 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares ($5,771,765)
Net Sell
11 txns
Insider
EDGEMOND JAMES
Role
CFO AND TREASURER
Sold
10,000 shs ($5.77M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 10,000 | $0.00 | -- |
| Exercise | Common Stock | 10,000 | $135.42 | $1.35M |
| Sale | Common Stock | 520 | $573.9146 | $298K |
| Sale | Common Stock | 1,680 | $574.733 | $966K |
| Sale | Common Stock | 789 | $575.6405 | $454K |
| Sale | Common Stock | 2,206 | $576.9149 | $1.27M |
| Sale | Common Stock | 2,085 | $577.8728 | $1.20M |
| Sale | Common Stock | 1,066 | $578.8269 | $617K |
| Sale | Common Stock | 1,454 | $579.6354 | $843K |
| Sale | Common Stock | 160 | $581.0825 | $93K |
| Sale | Common Stock | 40 | $581.64 | $23K |
Holdings After Transaction:
Stock Option — 82,500 shares (Direct);
Common Stock — 28,876 shares (Direct)
Footnotes (1)
- This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. This transaction was executed in multiple trades at prices ranging from $573.15 to $574.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $574.22 to $575.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $575.25 to $576.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $576.30 to $577.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $577.30 to $578.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $578.32 to $579.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $579.32 to $580.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $580.62 to $581.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Options exercised: 10,000 shares
Exercise price: $135.42/share
Shares sold: 10,000 shares
+4 more
7 metrics
Options exercised
10,000 shares
Stock options exercised into Common Stock on April 16, 2026 at $135.42
Exercise price
$135.42/share
Exercise price of stock options expiring March 15, 2027
Shares sold
10,000 shares
Open-market Common Stock sales on April 16, 2026
Sale prices range
$573.9146–$581.6400/share
Weighted average prices across multiple sale trades
Common Stock held after
18,876 shares
Direct ownership after all reported transactions
Options held after
82,500 options
Stock options remaining after 10,000-option exercise
Rule 10b5-1 plan date
October 31, 2025
Pre-arranged trading plan governing exercise and sales
Key Terms
Rule 10b5-1 trading plan, Stock Option, Common Stock, open-market sale, +1 more
5 terms
Rule 10b5-1 trading plan financial
"exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option financial
"security_title: "Stock Option" with an exercise price of $135.4200"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Common Stock financial
"underlying_security_title: "Common Stock" for 10,000.0000 underlying shares"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open-market sale financial
"transaction_action: "open-market sale" with transaction code "S""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What did UNITED THERAPEUTICS (UTHR) CFO James Edgemond do in this Form 4?
CFO James Edgemond exercised stock options for 10,000 UNITED THERAPEUTICS shares and sold 10,000 shares in the open market. The transactions occurred on April 16, 2026 and were reported as routine derivative exercises and sales.
What was the option exercise price for the UNITED THERAPEUTICS (UTHR) CFO?
The CFO exercised 10,000 stock options at an exercise price of $135.42 per share. These options, originally exercisable into Common Stock, had an expiration date of March 15, 2027, according to the derivative transaction details in the filing.
Were the UNITED THERAPEUTICS (UTHR) CFO’s trades made under a Rule 10b5-1 plan?
Yes. The footnotes state the option exercise and subsequent sale of shares were conducted under a Rule 10b5-1 trading plan. The reporting person entered this pre-arranged plan on October 31, 2025, indicating the trades were scheduled in advance.